Literature DB >> 15023417

Plasma cell differentiation and multiple myeloma.

Miriam Shapiro-Shelef1, Kathryn Calame.   

Abstract

Microarray analyses and gene targeting have recently enhanced the understanding of factors involved in normal plasma cells and multiple myeloma. Plasma cells develop from marginal zone or germinal center B cells following stimulation by antigen, microbial products, TNF family signals and cytokines. Transcription factors, B-lymphocyte-induced maturation protein 1 (Blimp-1) and X-box binding protein 1 (XBP-1) are required for plasma cell development. They regulate sets of genes that induce immunoglobulin secretion, halt proliferation and block alternative B-cell fates. In multiple myeloma, transforming events lead to proliferation and survival, but programs for plasma cell differentiation and the inhibition of B-cell genes appear to be largely intact.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023417     DOI: 10.1016/j.coi.2004.02.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  17 in total

1.  Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.

Authors:  Tsipi Shoham; Ranjani Rajapaksa; Chiung-Chi Kuo; Joseph Haimovich; Shoshana Levy
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

2.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

3.  DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

Authors:  Timothy R Peterson; Mathieu Laplante; Carson C Thoreen; Yasemin Sancak; Seong A Kang; W Michael Kuehl; Nathanael S Gray; David M Sabatini
Journal:  Cell       Date:  2009-05-14       Impact factor: 41.582

Review 4.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

Review 5.  Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.

Authors:  Kah Teong Soh; Joseph D Tario; Paul K Wallace
Journal:  Clin Lab Med       Date:  2017-12       Impact factor: 1.935

Review 6.  Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.

Authors:  G Shay; L Hazlehurst; C C Lynch
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

7.  Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy.

Authors:  Agata Desantis; Tiziana Bruno; Valeria Catena; Francesca De Nicola; Frauke Goeman; Simona Iezzi; Cristina Sorino; Maurilio Ponzoni; Gianluca Bossi; Vincenzo Federico; Francesca La Rosa; Maria Rosaria Ricciardi; Elena Lesma; Paolo D'Onorio De Meo; Tiziana Castrignanò; Maria Teresa Petrucci; Francesco Pisani; Marta Chesi; P Leif Bergsagel; Aristide Floridi; Giovanni Tonon; Claudio Passananti; Giovanni Blandino; Maurizio Fanciulli
Journal:  EMBO J       Date:  2015-03-14       Impact factor: 11.598

8.  Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation.

Authors:  Volkhard Seitz; Philippe E Thomas; Karin Zimmermann; Ulrike Paul; Anke Ehlers; Maria Joosten; Lora Dimitrova; Dido Lenze; Anke Sommerfeld; Elisabeth Oker; Ulf Leser; Harald Stein; Michael Hummel
Journal:  Haematologica       Date:  2011-03-10       Impact factor: 9.941

9.  A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Sudin Bhattacharya; Rory B Conolly; Norbert E Kaminski; Russell S Thomas; Melvin E Andersen; Qiang Zhang
Journal:  Toxicol Sci       Date:  2010-02-01       Impact factor: 4.849

10.  Splenic plasma cells can serve as a source of amyloidogenic light chains.

Authors:  Alan Solomon; Sallie D Macy; Craig Wooliver; Deborah T Weiss; Per Westermark
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.